In Depth 15 Aug 2022
Can phage therapy answer the booming antibiotic resistance problem?
Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective new antibiotics are thin on…
Phage therapy
- Latest Posts
In Depth 30 Dec 2020
A Look Back at the Past Decade of European Biotech
As we prepare to enter a new decade, we look back on the major milestones and blunders within European biotech…
In Depth 21 Dec 2020
Enemy or Valuable Ally? How Biotech Uses Viruses for Good
Taking advantage of the ability of viruses to manipulate life is opening new doors for the biotech industry. Once only…
News and Trends 29 Apr 2020
Pluristem Scores €50M From EIB to Develop Covid-19 Cell Therapy
Israeli cell therapy biotech Pluristem Therapeutics has secured up to €50M in non-dilutive funding from the European Investment Bank to…
ADVERTISEMENT
News and Trends 22 Oct 2019
Austrian Biotech Will Develop Viral Protein For Vaginal Infection
The Austrian biotech company PhagoMed Biopharma is developing a viral protein that could one day treat the common condition bacterial…
News and Trends 21 Feb 2019
Microbiome Biotech Will Use Series B to Bring Treatments to Clinic
The Israeli biotech BiomX has raised €28M ($32M) to advance its treatments for acne and inflammatory bowel disease to the…
News and Trends 20 Nov 2018
Genentech and Immunocore Expand Partnership to Develop Cancer Immunotherapy
Immunocore and the US biotech giant Genentech are building on their existing partnership to boost the clinical development of Immunocore's…
In Depth 25 Jul 2018
Could These Groundbreaking Therapies Make Conventional Antibiotics a Thing of the Past?
With the rise of antimicrobial resistance across the globe, and with a dire lack of new antibiotics in the pipeline,…
Interview 21 Mar 2018
Do Phages Hold the Key to Modulating the Microbiome?
The human microbiome is emerging as a target for treating a wide range of diseases, but it's still a young…
News and Trends 21 Aug 2017
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with the potential to treat multiple…
News and Trends 13 Sep 2016
The next generation of Antibiotics could be Bacteriophages
One of the last remaining bastions for organic chemists in pharmaceuticals is in antibiotic development. It is now under fire…
News and Trends 26 Oct 2015
The First Ever Oncolytic Immunotherapy is Set to Reach the European Market
Amgen is now months away from a European approval with Imlygic (also known as T-VEC) - the first oncolytic immunotherapy for advanced…
News and Trends 15 Sep 2015
Will bacteriophages solve the antibiotic resistance problem in the EU?
French Pherecydes Pharma has launched the first EU clinical bacteriophage phase I/II trial to fight hospital acquired infections (HAIs) in…
News and Trends 22 Jul 2015
Adaptimmune’s TCR Therapy Proves its Superiority over its Immuno-oncology Competitors
Adaptimmune Therapeutics, an oxford-based company focusing on the use of T-cell therapies to treat cancer, announced today that data from its…
